Unknown

Dataset Information

0

Management of Primary and Recurrent Clostridium difficile Infection: An Update.

ABSTRACT: BACKGROUND:Clostridium difficile infection (CDI) is one of the most common healthcare-associated infections (HAI) in the United States and Canada, and incidence rates have increased worldwide in recent decades. Currently, antibiotics are the mainstay treatments for both primary and recurrent CDI, but their efficacy is limited, prompting further therapies to be developed. Aim: This review summarizes current and emerging therapies in CDI management including antibiotics, fecal microbiota transplantation, monoclonal antibodies, spore-based therapies, and vaccinations.

SUBMITTER: Chai J 

PROVIDER: S-EPMC6163576 | biostudies-other | 2018 Jun

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Management of Primary and Recurrent <i>Clostridium difficile</i> Infection: An Update.

Chai Jocelyn J   Lee Christine H CH  

Antibiotics (Basel, Switzerland) 20180630 3

<h4>Background</h4><i>Clostridium difficile</i> infection (CDI) is one of the most common healthcare-associated infections (HAI) in the United States and Canada, and incidence rates have increased worldwide in recent decades. Currently, antibiotics are the mainstay treatments for both primary and recurrent CDI, but their efficacy is limited, prompting further therapies to be developed. <i>Aim:</i> This review summarizes current and emerging therapies in CDI management including antibiotics, feca  ...[more]

Similar Datasets

Unknown A Review of Management of Clostridium difficile Infection: Primary and Recurrence.
| S-EPMC4790304 | biostudies-other
Unknown Clostridium difficile infection: new insights into management.
| S-EPMC3541870 | biostudies-other
Unknown Role of Coinfecting Strains in Recurrent Clostridium difficile Infection.
| S-EPMC5560262 | biostudies-other
Unknown Recurrent Clostridium difficile infection: From colonization to cure.
| S-EPMC4492812 | biostudies-literature
Unknown Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis.
| S-EPMC4017891 | biostudies-other
Unknown Population Pharmacokinetics and Pharmacodynamics of Bezlotoxumab in Adults with Primary and Recurrent Clostridium difficile Infection.
| S-EPMC6355577 | biostudies-literature
Unknown Treatment of recurrent Clostridium difficile infection: a systematic review.
| S-EPMC3934353 | biostudies-literature
Unknown Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease.
| S-EPMC6274632 | biostudies-literature
Unknown Extended duration vancomycin in recurrent Clostridium difficile infection: a systematic review.
| S-EPMC6210635 | biostudies-other
Unknown Novel risk factors for recurrent Clostridium difficile infection in children.
| S-EPMC4276518 | biostudies-literature